Reoperation for brain metastases.

Sundaresan, Narayan; Sachdev, Ved P.; DiGiacinto, George V.; Hughes, James E. O.

doi:10.1200/jco.1988.6.10.1625

Cited by 65 publications

(18 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Anderson. The data from this article confirmed those of Sundaresan et al [34] in that the median survival time after resection was 11.5 months, with 2-year and 5-year survival rates of 26% and 17%, respectively. No operative morbidity or mortality occurred.…”

Section: Recurrent Brain Metastasessupporting

confidence: 93%

See 1 more Smart Citation

Surgical management of brain metastases

2001

View full text Add to dashboard Cite

Metastatic brain tumors are the most common intracranial tumors in adults and the most common cause of neurologic morbidity and mortality in these patients. Recent advances in the management of the primary cancer have resulted in improved prognosis, longer survival, and thus, increased identification of the presence of brain metastases. Data suggest that aggressive treatment of the metastatic brain tumor with surgical resection increases the length of survival in these patients. New techniques, including preoperative functional imaging, stereotactic surgical resection, image-guided neurosurgery, intraoperative ultrasound, and cortical mapping, have aided neurosurgeons in surgical resection and have helped to lower the associated surgical morbidity and mortality. The respective roles of surgery, patient selection, prognostic factors, and radiotherapy are addressed in this review.

show abstract

Section: Recurrent Brain Metastasessupporting

confidence: 93%

“…According to the first such report, by Sundaresan et al [34] in 1988, 21 patients originally treated with surgery for single brain metastases underwent repeat craniotomy for the recurrent lesion. These patients survived for a median of 9 months after the second surgery, and 24% of patients survived for more than 2 years.…”

Section: Recurrent Brain Metastasesmentioning

confidence: 99%

Surgical management of brain metastases

2001

View full text Add to dashboard Cite

show abstract

“…Past studies have shown that repeat NS in select patients can result in neurologic improvement with minimal morbidity and mortality as reported here [12]. Local recurrence after resection can occur in up to 46% of cases [13].…”

Section: Treatment Of Brain Metastasis In Breast Cancersupporting

confidence: 60%

Long-Term Disease-Free Survival in a Young Patient With Hormone Receptor–Positive Breast Cancer and Oligometastatic Disease in the Brain

Saha

Amico

Olopade

2016

Clinical Breast Cancer

View full text Add to dashboard Cite

“…Surgical resection may have a role in selected patients with symptomatic recurrent lesions. Patients with good performance status, controlled systemic disease, and a long interval after initial resection are most likely to benefit from reoperation [33][34][35]. Cost effectiveness The cost of a craniotomy is approximately $10,000 to $20,000, whereas that for a stereotactic biopsy is $7,000 to $12,000.…”

Section: Surgerymentioning

confidence: 99%

Brain metastases

Wen

Loeffler

2000

Curr. Treat. Options in Oncol.

View full text Add to dashboard Cite

Brain metastases are an increasingly common complication in patients with systemic cancer. The optimal treatment for each patient depends on careful evaluation of several factors: the location, size, and number of brain metastases; the patient's age, general condition, and neurologic status; and the extent of systemic cancer to name a few. For patients with a single brain metastasis and limited systemic disease, the standard treatment is surgical resection followed by whole brain radiation therapy. In patients with a small, single metastasis, stereotactic radiosurgery is probably comparable to surgery. Patients with several metastases (up to three) and controlled systemic disease can be treated with whole-brain radiation and stereotactic radiosurgery. Patients with multiple metastases (more than three) are generally treated with whole-brain radiation alone. Radiosurgery is effective in treating patients with a limited number of recurrent brain metastases and stable systemic diseases. Surgery may have a role in patients with a large symptomatic recurrent lesion producing mass effect. Reirradiation and chemotherapy may have a limited role in patients with multiple recurrent metastases.

show abstract

Reoperation for brain metastases.

Cited by 65 publications

References 20 publications

Surgical management of brain metastases

Surgical management of brain metastases

Long-Term Disease-Free Survival in a Young Patient With Hormone Receptor–Positive Breast Cancer and Oligometastatic Disease in the Brain

Brain metastases

Contact Info

Product

Resources

About